For research studies approved to conduct in-person activities, researchers must provide each participant being seen with the below IRB-approved COVID-19 Risk Information Sheet using the following procedures:

1. Research teams must attempt to contact each participant before their scheduled research visit to provide this information about COVID-19 risks.
2. When participants arrive for a research-related visit, the study team must confirm that the participant has received this information. If not, then this information must be provided at that time.

• COVID-19 Research Participant Risk Information Sheet - Revised version posted 1/5/2022
• Spanish Translation of COVID-19